Current knowledge of immunosuppression as a risk factor for skin cancer development

被引：15
作者：
Rollan, Maria Paz [1 ,2 ]
Cabrera, Raul [1 ,2 ]
Schwartz, Robert A. [3 ]
机构：
[1] Univ Desarrollo, Dept Dermatol, Clin Alemana, Santiago, Chile
[2] Univ Desarrollo, Clin Alemana, Santiago, Chile
[3] Rutgers New Jersey Med Sch, Dermatol Med & Pathol, Newark, NJ USA
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2022年 / 177卷
关键词：
Skin Neoplasms; Immunosuppression; Primary Immunodeficiency Diseases; Transplant recipients; HIV; Immunosuppressive Agents; Melanoma; Carcinoma; Squamous Cell; ORGAN TRANSPLANT RECIPIENTS; INFLAMMATORY-BOWEL-DISEASE; T-CELL LYMPHOMA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; CUTANEOUS MALIGNANT-MELANOMA; HIV-INFECTED PATIENTS; KAPOSI-SARCOMA; UNITED-STATES; RHEUMATOID-ARTHRITIS; METHOTREXATE TREATMENT;
D O I：
10.1016/j.critrevonc.2022.103754
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review outlines our current understanding of the relationship between immunosuppression and skin cancer. Primary immunodeficiencies increase the incidence of skin cancer, but due to their low frequency, the establishment of accurate risk ratios remains lacking. Regarding secondary immunosuppression, available data demonstrate a significant increase of skin cancer in solid organ recipients, being the most common malignancy of this population. Immunosuppressive drugs have an important role in these patients, with an impact related to both the cumulative dose and the type of regimen used. The association of skin cancer and immunosuppressive drugs in non-transplant patients is conflictive for most of the drugs except for azathioprine. Many cancers lead to secondary immunosuppression as a mechanism for tumor growth and advancement, increasing the risk of progression of the primary tumor. Novel insights related with tumorigenesis and immune-escape mechanisms have led to promising new treatments in melanoma and squamous cell carcinoma.
引用
收藏
页数：12
相关论文
共 161 条
  • [1] Risk of Melanoma and Non-Melanoma Skin Cancer in Ulcerative Colitis Patients Treated With Thiopurines: A Nationwide Retrospective Cohort
    Abbas, Ali M.
    Almukhtar, Rawaa M.
    Loftus, Edward V., Jr.
    Lichtenstein, Gary R.
    Khan, Nabeel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (11) : 1781 - 1793
  • [2] Etiology of increased cancer incidence after solid organ transplantation
    Acuna, Sergio A.
    [J]. TRANSPLANTATION REVIEWS, 2018, 32 (04) : 218 - 224
  • [3] Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada
    Acuna, Sergio A.
    Fernandes, Kimberly A.
    Daly, Corinne
    Hicks, Lisa K.
    Sutradhar, Rinku
    Kim, S. Joseph
    Baxter, Nancy N.
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 463 - 469
  • [4] Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation
    Aguiar, Diego
    Martinez-Urbistondo, Diego
    D'Avola, Delia
    Inarrairaegui, Mercedes
    Pardo, Fernando
    Rotellar, Fernando
    Sangro, Bruno
    Quiroga, Jorge
    Ignacio Herrero, Jose
    [J]. ANNALS OF TRANSPLANTATION, 2017, 22 : 141 - 147
  • [5] Viral oncogenesis and its role in nonmelanoma skin cancer
    Arron, S. Tuttleton
    Jennings, L.
    Nindl, I.
    Rosl, F.
    Bavinck, J. N. Bouwes
    Seckin, D.
    Trakatelli, M.
    Murphy, G. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (06) : 1201 - 1213
  • [6] Do steroids increase lymphoma risk?: A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
    Askling, J
    Klareskog, L
    Hjalgrim, H
    Baecklund, E
    Björkholm, M
    Ekbom, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1765 - 1768
  • [7] Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
    Askling, Johan
    Fahrbach, Kyle
    Nordstrom, Beth
    Ross, Susan
    Schmid, Christopher H.
    Symmons, Deborah
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (02) : 119 - 130
  • [8] DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients
    Aydin, Susanne E.
    Kilic, Sara Sebnem
    Aytekin, Caner
    Kumar, Ashish
    Porras, Oscar
    Kainulainen, Leena
    Kostyuchenko, Larysa
    Genel, Ferah
    Kutukculer, Necil
    Karaca, Neslihan
    Gonzalez-Granado, Luis
    Abbott, Jordan
    Al-Zahrani, Daifulah
    Rezaei, Nima
    Baz, Zeina
    Thiel, Jens
    Ehl, Stephan
    Marodi, Laszlo
    Orange, Jordan S.
    Sawalle-Belohradsky, Julie
    Keles, Sevgi
    Holland, Steven M.
    Sanal, Ozden
    Ayvaz, Deniz C.
    Tezcan, Ilhan
    Al-Mousa, Hamoud
    Alsum, Zobaida
    Hawwari, Abbas
    Metin, Ayse
    Matthes-Martin, Susanne
    Hoenig, Manfred
    Schulz, Ansgar
    Picard, Capucine
    Barlogis, Vincent
    Gennery, Andrew
    Ifversen, Marianne
    van Montfrans, Joris
    Kuijpers, Taco
    Bredius, Robbert
    Duckers, Gregor
    Al-Herz, Waleed
    Pai, Sung-Yun
    Geha, Raif
    Notheis, Gundula
    Schwarze, Carl-Philipp
    Tavil, Betul
    Azik, Fatih
    Bienemann, Kirsten
    Grimbacher, Bodo
    Heinz, Valerie
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (02) : 189 - 198
  • [9] Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
    Baecklund, E
    Iliadou, A
    Askling, J
    Ekborn, A
    Backlin, C
    Granath, F
    Catrina, AT
    Rosenquist, R
    Feltelius, N
    Sundström, C
    Klareskog, L
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 692 - 701
  • [10] The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines
    Bahi, Morwan
    Walmsley, Russell S.
    Gray, Andrew R.
    Young, David
    Hobbs, Catherine E.
    Aluzaite, Kristina
    Schultz, Michael
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1047 - 1052
12345678910